HO-1 upregulation has been shown in vivo to induce a protective effect against airway inflammation in allergic asthma and skin allergy models, potentially through the mechanism of enhancing expansion and suppression functions of CD4+/CD25+ Treg cells (27–29). This evidence concerns the gene HMOX1 and allergic asthma.